Records containing: Male Breast Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-10-29Male breAsT cAncer preDisposition Factor: Creation of a Control Cohort 2
-
CLINICAL_TRIALS study record update · 2026-10-26Phase I Trial of Ixabepilone and Vorinostat in Metastatic Breast Cancer
-
CLINICAL_TRIALS study record update · 2026-03-27Adaption of the EORTC Quality of Life Breast Cancer Module for Male Breast Cancer - Phase I
-
CLINICAL_TRIALS study record update · 2026-01-07ETHAN: A Phase II Study Comparing Different Endocrine THerapies for mAle Breast caNcer
-
CLINICAL_TRIALS study record update · 2024-08-09T&T Trial: Adding Testosterone to Tamoxifen in Male Breast Cancer Patients
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-07-31Biologic Endpoints in the Annihilation of Metastases for Oligometastasis (BEAM ON)
-
CLINICAL_TRIALS study record update · 2024-05-10Finasteride and Male Breast Cancer - A Register-Based Nested Case-Control Study in Denmark, Finland, Norway, and Sweden
-
CLINICAL_TRIALS study record update · 2024-03-07Phase II Trial of Raf Kinase Inhibitor BAY 43-9006 as Single Oral Agent in Patients With Metastatic Breast Cancer Previously Exposed to Anthracycline and/or Taxane
-
CLINICAL_TRIALS study record update · 2022-12-06A Pilot Study of Beta-Blockers in Patients With Advanced Cancer
-
CLINICAL_TRIALS study record update · 2022-10-13LCI-BRE-H2N-PEPP-001: A Pilot Study of Paclitaxel Plus Pembrolizumab in Patients With Metastatic HER2-Negative Breast Cancer (The PePPy Trial)
-
CLINICAL_TRIALS study record update · 2021-03-11Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer
-
CLINICAL_TRIALS study record update · 2020-02-12Phase II Study of a HER-2/Neu (HER2) Intracellular Domain (ICD) Peptide-Based Vaccine Administered to Patients With Locally Advanced or Stage IV HER2 Positive Breast Cancer
-
CLINICAL_TRIALS study record update · 2020-02-10Phase I-II Study of HER2 Vaccination With Poly(I) • Poly(C12U) (Ampligen®) as an Adjuvant in Optimally Treated Breast Cancer Patients
-
CLINICAL_TRIALS study record update · 2019-11-12Phase 1b/2 Single-arm Trial Evaluating the Combination of Lapatinib, Everolimus and Capecitabine for the Treatment of Patients With HER2-positive Metastatic Breast Cancer With CNS Progression After Trastuzumab
-
CLINICAL_TRIALS study record update · 2019-11-05Phase I Trial of Ixabepilone and Vorinostat in Metastatic Breast Cancer
-
CLINICAL_TRIALS study record update · 2019-10-30A Randomized, Placebo-Controlled Phase II Clinical Trial of Omega-3 PUFA Dietary Supplementation in Patients With Stage I-III Breast Carcinoma
-
CLINICAL_TRIALS study record update · 2019-09-06Phase 1-2 18F-FPPRGD2 PET/CT or PET/MRI Imaging of αvβ3 Integrins Expression as a Biomarker of Angiogenesis
-
CLINICAL_TRIALS study record update · 2019-06-07Phase II Neoadjuvant Trial With Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients
-
CLINICAL_TRIALS study record update · 2019-02-01A Phase 1/2 Open-Label Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of Seviteronel in Subjects With Advanced Breast Cancer
-
CLINICAL_TRIALS study record update · 2018-10-09A Phase I Trial of the Safety and Immunogenicity of a Multi-epitope HER-2/Neu Peptide Vaccine in Subjects Previously Treated for HER-2 Positive Breast Cancer
-
CLINICAL_TRIALS study record update · 2018-09-19A Prospective, Randomised, Multi-centre Phase II Study Evaluating the Adjuvant, Neoadjuvant or Palliative Treatmant With Tamoxifen +/- GnRH Analogue Versus Aromatase Inhibitor + GnRH Analogue in Male Breast Cancer Patients
-
CLINICAL_TRIALS study record update · 2018-09-12A Randomized Phase I Trial of Nanoparticle Albumin Bound Paclitaxel (Nab-paclitaxel, Abraxane) With or Without Mifepristone for Advanced Breast Cancer
-
CLINICAL_TRIALS study record update · 2018-09-11Carboplatin, Gemcitabine, and Mifepristone for Advanced Breast Cancer and Recurrent or Persistent Epithelial Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2018-07-26Neo-adjuvant Therapy With Anastrozole Plus Pazopanib in Stage II and III ER+ Breast Cancer
-
CLINICAL_TRIALS study record update · 2018-06-14A Phase I Clinical Trial of Ganetespib (Heat Shock Protein 90 Inhibitor) in Combination With Paclitaxel, Trastuzumab and Pertuzumab in Human Epidermal Growth Factor Receptor-2 Positive (HER2+) Metastatic Breast Cancer